News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Pavlos Msaouel: How the observed adjuvant immunotherapy trial result discrepancies in kidney cancer
Pavlos Msaouel/X
Nov 2, 2024, 12:42

Pavlos Msaouel: How the observed adjuvant immunotherapy trial result discrepancies in kidney cancer

Pavlos Msaouel, Assistant Professor at MD Anderson Cancer Center, shared a post on X:

“Commentary European Urology led by Daniel Shapiro on how the observed adjuvant immunotherapy trial result discrepancies in kidney cancer can be explained by simple trial design principles.

Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to Power

Authors: Daniel Shapiro, Pavlos Msaouel.”

Pavlos Msaouel: How the observed adjuvant immunotherapy trial result discrepancies in kidney cancer

Pavlos Msaouel: How the observed adjuvant immunotherapy trial result discrepancies in kidney cancer

 

adjuvant immunotherapy cancer Daniel Shapiro european urology kidney cancer OncoDaily Oncology Pavlos Msaouel
Special Coverage
Oncolibrary
Jun 1, 2025, 18:59
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
Blog
Jun 1, 2025, 18:25
Project Cure CRC has awarded 4 new grants - Colorectal Cancer Alliance
Blog
Jun 1, 2025, 18:09
Michael Jefford: Grateful for ASCO25’s Valuable Survivorship Session
Stories
Jun 1, 2025, 17:19
Shrenik Shah’s Story from Cancer Survivor to Global Advocate: From Silence to Stages
Insight
Jun 1, 2025, 17:02
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Blog
Jun 1, 2025, 16:55
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Blog
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Insight
Jun 1, 2025, 16:46
Shanda Blackmon: First trial of CAR-T cell cancer treatment for solid tumor response
Oncolibrary
Jun 1, 2025, 16:39
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
Opinion
Jun 1, 2025, 16:37
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments
Blog
Jun 1, 2025, 16:37
Paolo Tarantino Shares DB06 Biomarker Analysis Insights from ASCO 2025
Insight
Jun 1, 2025, 16:36
Rebecca Shatsky: It’s high time for an oral taxane in breast cancer